Tag: U.S. Food and Drug Administration
FDA Acknowledges Coronavirus Is Causing More Drug Shortages

The first outbreak of the coronavirus occurred in China nearly two months ago. The disease quickly spread through the country. As of March 5th, the coronavirus is responsible for over 80,000 confirmed cases and nearly 3,400 deaths across China. Globally over 98,000 people are infected, resulting in nearly 4,000 deaths. At this time, the...
Read More »

FDA’s Approval of Generic Daraprim Offers Lessons on Drugs Prices

In 2015, Turning Pharmaceuticals CEO Martin Shkreli increased the price of the drug Daraprim nearly 5,000 percent from $13.50 to $750 per pill. The price hike generated widespread outrage, earning Shkreli the moniker “Pharma Boy” and the designation, “pharmaceutical greed villain.” Daraprim became “the poster child for the issue of high drug prices.”

FDA Expands Ecstasy Access to Veterans with PTSD

In 2006, Johnathan Lubecky was deployed to Iraq. While fighting for his country, Johnathan faced constant enemy strikes, one of which resulted in a traumatic brain injury. Exposures to the horrors of war resulted in Johnathan developing post-traumatic stress disorder (PTSD).

As Insulin Prices Rise, Diabetics Turn to Black Markets

To avoid financial hardship and medical complications, many diabetics have turned to black markets.

FDA To Stop Regulating the Amount of Cherries in Frozen Cherry Pie

The FDA recently committed to deregulating the frozen cherry pie market.

Political Rhetoric Against Right-to-Try Laws Continues, Undermining Support for Medical Treatments of Last Resort

Ms. Joy Silver’s criticisms of right-to-try laws are ill-conceived.

FDA Approves Ketamine-Based Drug to Treat Difficult Cases of Depression

Despite its reputation as a party drug, Ketamine is now hailed as a “game-changing” treatment for types of depression that do not respond to typical treatment methods.

FDA Wants More Sunscreen Regulations, but Would Consumers Get Burned?

Attempts to find “the right balance” are more likely to throw the sunscreen market wildly out of balance.

FDA Panel Backs Ketamine-Based Treatment for Depression

Despite its exciting potential, esketamine is receiving significantly more attention for being similar to the street drug ketamine.

FDA Considers Regulating E-cigarette Juices

Despite the best of intentions, efforts to regulate vice frequently fail and can lead to harmful secondary effects for those they intend to help.

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org